Analyst Price Target is $85.60
▲ +35.36% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Establishment Labs in the last 3 months. The average price target is $85.60, with a high forecast of $90.00 and a low forecast of $78.00. The average price target represents a 35.36% upside from the last price of $63.24.
Current Consensus is
The current consensus among 5 polled investment analysts is to buy stock in Establishment Labs. This Buy consensus rating has held steady for over two years.
Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. It operates through the following geographical segments: Europe, Latin America, Asia Pacific and Middle East, and Other. The firm's products include Motiva Implants, Motiva Flora Tissue Expander, Divina, and Puregraft. The company was founded by Juan Jose Chacon-Quiros in 2004 and is headquartered in Alajuela, Costa Rica.